Telik

Telik Inc
IndustryHealthcare, Drug Manufacturers - Other
Founded1988
Headquarters
Palo Alto, California
,
United States
Key people
Michael M. Wick M.D.
( Chairman, Chief Executive Officer, and President)

Wendy K. Wee
( Principal Financial & Accounting Officer )

Gail L. Brown M.D.
( Chief Medical Officer )
(Dec 31, 2012)
Number of employees
17 (Dec 31, 2012)
Websitetelik.com Edit this on Wikidata

Telik, Inc. was set up in 1988 and was reverse merged into privately held MabVax in May 2014.[1] The major drug of the company was TELINTRA, an investigational agent that was in development for the treatment of myelodysplastic syndrome (MDS) and idiopathic chronic neutropenia.[2]

Controversies

In 2007, a class action was filed against Telik, Inc., alleging that they made false and misleading statements about the Company’s business and prospects during the Class Period.[3]

References

  1. ^ "Reverse merger".
  2. ^ "Business Summary".
  3. ^ "Lerach Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against Telik, Inc".
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.